Dennis Gilbert has left his position as chief scientific officer and vice president for research at Applied Biosystems as of Aug. 1, a company spokesman confirmed last week. Gilbert resigned to “pursue other career interests,” said the spokesman, who was unable to provide further information on Gilbert’s plans or whether the company is seeking a replacement.
In addition to his positions as CSO and VP of research, Gilbert managed ABI’s Advanced Research and Technology organization, which is responsible for identifying and developing new technologies and applications.
During his tenure of more than 12 years with ABI, Gilbert held a number of other positions, including vice president of advanced research and technology, vice president of genomics applications, and vice president of gene discovery at ABI’s sister company Celera Genomics.
Prior to joining ABI, he was program manager of genetics at W.R. Grace.
Gilbert holds a BS degree biochemistry and cell biology from the University of California, San Diego, and a PhD in genetics from Johns Hopkins University.
Clive Brown has joined the Wellcome Trust Sanger Institute as a group leader in next-generation sequencing informatics R&D.
Previously, he was director of computational biology and IT at Solexa in Little Chesterford, UK, which he joined in late 2002. He left the company in January prior to the its merger with Illumina.
“When I joined I had a mental target of what I wanted to achieve, and by January 2007, most of that was in place,” he told In Sequence by e-mail this week.